Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for BeiGene Ltd.
Goto 0, 1, 2, ...5, 6, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-09-24
Purchase
2021-09-28
5:48 pm
LEAP THERAPEUTICS Inc LPTX BeiGene Ltd.
10% Owner
2,543,800 $2.85 $7,249,830 7,348,437
(Direct)
View
2021-09-14
Sale
2021-09-16
6:06 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
347,803 $28.82 $10,022,365 47,814,827
(Indirect
Direct)
View
2021-08-31
Sale
2021-09-02
8:40 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
204,358 $24.09 $4,922,921 47,814,827
(Indirect
Direct)
View
2021-08-04
Sale
2021-08-05
9:03 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
83,200 $25.97 $2,160,781 47,814,827
(Indirect
Direct)
View
2021-08-03
Sale
2021-08-05
9:01 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
41,400 $25.17 $1,041,881 47,814,827
(Indirect
Direct)
View
2021-07-22
Sale
2021-07-22
6:23 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
57,900 $23.71 $1,373,070 47,814,827
(Indirect
Direct)
View
2021-07-20
Sale
2021-07-22
6:21 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
39,600 $24.6 $974,108 47,814,827
(Indirect
Direct)
View
2021-07-07
Sale
2021-07-08
7:11 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
51,300 $24.24 $1,243,717 47,814,827
(Indirect
Direct)
View
2021-07-06
Sale
2021-07-08
7:09 pm
BeiGene Ltd. BGNE OYLER JOHN
CEO
85,000 $25.29 $2,149,295 47,815,127
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-05-17
Exercise
2022-05-19
4:39 pm
N/A
N/A
BeiGene Ltd. BGNE Wang Lai
Global Head of R & D
999,999 $3.49 1,466,686
(Direct)
View
2022-05-17
Exercise
2022-05-19
4:39 pm
N/A
2026-07-13
BeiGene Ltd. BGNE Wang Lai
Global Head of R & D
1,233,947 $0 1,466,686
(Direct)
View
2022-05-17
Exercise
2022-05-19
4:39 pm
N/A
N/A
BeiGene Ltd. BGNE Wang Lai
Global Head of R & D
233,948 $2.29 1,466,686
(Direct)
View
2022-02-28
Option Award
2022-03-02
5:12 pm
N/A
N/A
BeiGene Ltd. BGNE Wang Julia Aijun
CFO
61,750 $0 143,299
(Direct)
View
2022-02-28
Option Award
2022-03-02
5:10 pm
N/A
2032-02-27
BeiGene Ltd. BGNE Riva Alessandro
Director
22,581 $0 22,581
(Direct)
View
2022-02-28
Option Award
2022-03-02
5:07 pm
N/A
2032-02-27
BeiGene Ltd. BGNE Dugan Margaret
Director
22,581 $0 22,581
(Direct)
View
2021-12-15
Option Award
2021-12-17
5:05 pm
N/A
N/A
BeiGene Ltd. BGNE Wang Lai
Global Head of R & D
0 $30.13 174,551
(Indirect)
View
2021-12-15
Gift
2021-12-17
5:05 pm
N/A
N/A
BeiGene Ltd. BGNE Wang Lai
Global Head of R & D
116,376 $0 174,551
(Direct)
View
2021-12-15
Option Award
2021-12-17
5:03 pm
N/A
N/A
BeiGene Ltd. BGNE Wu Xiaobin
COO
0 $30.13 968,261
(Indirect)
View
2021-12-14
Exercise
2021-12-16
5:50 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
1,500 $119.96 371,331
(Direct)
View
2021-12-14
Exercise
2021-12-16
5:50 pm
N/A
2029-06-04
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
19,500 $0 371,331
(Direct)
View
2021-11-30
Option Award
2021-12-02
6:21 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
15,869 $0 0
(Direct)
View
2021-11-17
Exercise
2021-11-19
6:18 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
1,500 $119.96 376,011
(Direct)
View
2021-11-17
Exercise
2021-11-19
6:18 pm
N/A
2029-06-04
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
19,500 $0 376,011
(Direct)
View
2021-10-19
Exercise
2021-10-21
5:37 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
1,500 $119.96 395,511
(Direct)
View
2021-10-19
Exercise
2021-10-21
5:37 pm
N/A
2029-06-04
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
19,500 $0 395,511
(Direct)
View
2021-09-20
Exercise
2021-09-22
6:15 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
6,000 $119.96 415,011
(Direct)
View
2021-09-20
Exercise
2021-09-22
6:15 pm
N/A
2029-06-04
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
78,000 $0 415,011
(Direct)
View
2021-08-31
Option Award
2021-09-02
8:39 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
15,374 $0 0
(Direct)
View
2021-07-15
Exercise
2021-07-19
4:43 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
6,914 $160.4 974,206
(Direct)
View
2021-07-15
Exercise
2021-07-19
4:43 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
8,831 $119.96 974,206
(Direct)
View
2021-07-15
Exercise
2021-07-19
4:43 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
5,255 $174.43 974,206
(Direct)
View
2021-07-15
Exercise
2021-07-19
4:43 pm
N/A
2028-06-25
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
273,000 $0 974,206
(Direct)
View
2021-06-30
Ownership
2021-07-01
4:55 pm
N/A
N/A
BeiGene Ltd. BGNE Wang Julia Aijun
CFO
0 $0 366,483
(Direct)
View
2021-06-28
Exercise
2021-06-30
4:49 pm
N/A
N/A
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
1,500 $29.49 506,236
(Direct)
View
2021-06-28
Exercise
2021-06-30
4:49 pm
N/A
2026-09-02
BeiGene Ltd. BGNE Huang Jane
CMO Hematology
19,500 $0 506,236
(Direct)
View
2021-06-16
Option Award
2021-06-24
12:26 pm
N/A
2031-06-15
BeiGene Ltd. BGNE Yi Qingqing
Director
25,298 $0 25,298
(Direct)
View
2021-06-16
Option Award
2021-06-21
4:57 pm
N/A
2031-06-15
BeiGene Ltd. BGNE OYLER JOHN
CEO
1,053,156 $0 55,658,639
(Direct)
View
2021-06-16
Option Award
2021-06-21
4:50 pm
N/A
2031-06-15
BeiGene Ltd. BGNE Wang Xiaodong
Chairman
280,839 $0 11,699,072
(Direct)
View
Goto 0, 1, 2, ...5, 6, Next